Quest Partners LLC Haemonetics Corp Transaction History
Quest Partners LLC
- $753 Billion
- Q4 2024
A detailed history of Quest Partners LLC transactions in Haemonetics Corp stock. As of the latest transaction made, Quest Partners LLC holds 1,831 shares of HAE stock, worth $112,258. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,831
Previous 5
36520.0%
Holding current value
$112,258
Previous $402,000
35463.18%
% of portfolio
0.02%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding HAE
# of Institutions
344Shares Held
55.1MCall Options Held
689KPut Options Held
345K-
Black Rock Inc. New York, NY5.96MShares$365 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.18MShares$318 Million0.01% of portfolio
-
Neuberger Berman Group LLC New York, NY4.42MShares$271 Million0.29% of portfolio
-
Capital Research Global Investors Los Angeles, CA4.24MShares$260 Million0.07% of portfolio
-
Wellington Management Group LLP Boston, MA3.94MShares$242 Million0.06% of portfolio
About HAEMONETICS CORP
- Ticker HAE
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 51,316,500
- Market Cap $3.15B
- Description
- Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...